# Defining the role of menin in the Ewing sarcoma stress response

> **NIH NIH F31** · UNIVERSITY OF MICHIGAN AT ANN ARBOR · 2020 · $37,520

## Abstract

PROJECT SUMMARY
Cancer cells must respond to microenvironmental stress during tumor growth and metastasis in order maintain
metabolic homeostasis and support cell survival. ATF4 is a stress-induced master transcription factor that is
frequently upregulated in cancer. ATF4 activates gene expression programs that allow cells to respond to
stresses, such as nutrient and amino acid limitation, hypoxia, and oxidative stress. Previously published work
from the Lawlor lab revealed that the scaffolding protein menin promotes Ewing sarcoma tumorgenicity and
identified metabolic and stress response pathways, including the serine biosynthesis pathway, as downstream
targets of menin. Ewing sarcoma is a bone and soft tissue tumor that is most commonly driven by the EWS-FLI1
oncogene. Although survival rates for patients with localized tumors have improved, despite maximally intensive
therapy, Ewing sarcoma remains lethal for a third of patients, and event free and overall survival rates for patients
with metastatic disease are dismal. To this day, efforts to target the pathognomonic EWS-FLI1 fusion protein
have been largely unsuccessful, requiring the identification novel therapeutic targets and strategies. The
scaffolding protein menin can function as a tumor suppressor or as an oncogene in cancer. Menin can regulate
gene expression in both epigenetic-dependent and -independent manners, depending on its interaction with
several different protein-binding partners. Our preliminary data show that EWS-FLI1 contributes to regulation of
menin and its control of cell metabolism. In particular, we have found that, in Ewing sarcoma, ATF4 is highly
expressed and maintains Ewing sarcoma cell proliferation by regulating stress response pathways, including the
serine synthesis pathway. In addition, our studies show that ATF4 expression is modulated by menin. This
proposal will test the central hypothesis that a novel EWS-FLI1-menin-ATF4 axis functions in Ewing
sarcoma to promote cellular adaptation to stress, and that this axis is required for maintenance of
metabolic homeostasis and tumorgenicity. This hypothesis will be tested through two specific aims. Aim 1
will investigate the molecular mechanism(s) by which menin regulates ATF4 in Ewing sarcoma, and the biological
significance of this axis in response to stress. Aim 2 will elucidate the contribution of the EWS-FLI1 oncogene
to maintaining high-level menin expression as part of this stress-response axis. To accomplish these specific
aims, menin, ATF4, and EWS-FLI1 gain and loss-of-function in vitro models; metabolic profiling; and in vivo
metastasis models will be used to study the impact of EWS-FLI1 and/or menin modulation on ATF4-dependent
Ewing sarcoma cell survival and response to stress. The results from these innovative studies will define
cooperative mechanisms between EWS-FLI1 and menin in regulation of stress response pathways in Ewing
sarcoma, with the overall goal of identifying new therapeutic opportunit...

## Key facts

- **NIH application ID:** 10066562
- **Project number:** 1F31CA254079-01
- **Recipient organization:** UNIVERSITY OF MICHIGAN AT ANN ARBOR
- **Principal Investigator:** Jennifer Andrea Jiménez
- **Activity code:** F31 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2020
- **Award amount:** $37,520
- **Award type:** 1
- **Project period:** 2020-07-01 → 2023-06-30

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10066562

## Citation

> US National Institutes of Health, RePORTER application 10066562, Defining the role of menin in the Ewing sarcoma stress response (1F31CA254079-01). Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/grant/nih/10066562. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*